UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects

Clinical pharmacology in drug development, 2013-10, Vol.2 (4), p.310-315

2013

Link zum Volltext

Verfügbarkeit prüfen

Antihypertensive Response to Ketanserin: Influence of Race and Weight

Journal of clinical pharmacology, 1988-11, Vol.28 (11), p.1017-1022

1988

Link zum Volltext

Verfügbarkeit prüfen

Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects

European journal of clinical pharmacology, 2011-05, Vol.67 (5), p.483-492

2011

Link zum Volltext

Verfügbarkeit prüfen

Disposition of 14C-eptifibatide after intravenous administration to healthy men

Clinical therapeutics, 1998-03, Vol.20 (2), p.307-323

1998

Link zum Volltext

Verfügbarkeit prüfen

Drug interactions involving renal transport mechanisms: an overview

DICP (Cincinnati, Ohio), 1989-02, Vol.23 (2), p.116

1989

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Antacid and Cimetidine on the Oral Absorption of the Antifungal Agent SCH 39304

Journal of clinical pharmacology, 1990-07, Vol.30 (7), p.638-642

1990

Link zum Volltext

Verfügbarkeit prüfen

The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe

Current medical research and opinion, 2005-08, Vol.21 (8), p.1171-1179

2005

Link zum Volltext

Verfügbarkeit prüfen

Effect of Food, Antacid, and Age on the Pharmacokinetics of the Oral Thrombin Receptor Antagonist Vorapaxar (SCH 530348) in Healthy Volunteers

Clinical pharmacology in drug development, 2013-07, Vol.2 (3), p.223-230

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of Food on the Oral Bioavailability of Isosorbide-5-Mononitrate Administered as an Extended-Release Tablet

Journal of clinical pharmacology, 1995-02, Vol.35 (2), p.151-158

1995

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Multiple Doses of Ketoconazole or Rifampin on the Single- and Multiple-Dose Pharmacokinetics of Vorapaxar

Journal of clinical pharmacology, 2013-05, Vol.53 (5), p.540-549

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of the thrombin receptor antagonist (PAR-1) vorapaxar on QT/QTc interval in healthy volunteers: A randomized, placebo- and positive-controlled, parallel group trial

Clinical pharmacology in drug development, 2014-01, Vol.3 (1), p.18-24

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of Ezetimibe on Cyclosporine Pharmacokinetics in Healthy Subjects

Journal of clinical pharmacology, 2006-03, Vol.46 (3), p.321-327

2006

Link zum Volltext

Verfügbarkeit prüfen

Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin

Current medical research and opinion, 2004-06, Vol.20 (6), p.955-965

2004

Link zum Volltext

Verfügbarkeit prüfen

Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers

Clinical pharmacology and therapeutics, 1991-08, Vol.50 (1), p.181-191

1991

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device

Clinical pharmacology in drug development, 2014-05, Vol.3 (3), p.222-228

2014

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects

Clinical pharmacology in drug development, 2014-05, Vol.3 (3), p.229-234

2014

Link zum Volltext

Verfügbarkeit prüfen

Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactions

Clinical pharmacokinetics, 2005-01, Vol.44 (5), p.467-494

2005

Link zum Volltext

Verfügbarkeit prüfen

Influence of Food on the Oral Bioavailability of Loratadine and Pseudoephedrine from Extended-Release Tablets in Healthy Volunteers

Journal of clinical pharmacology, 1996-10, Vol.36 (10), p.923-930

1996

Link zum Volltext

Verfügbarkeit prüfen

The Influence of Multiple-Dose Vorapaxar, an Oral PAR-1 Receptor Antagonist, on the Single-Dose Pharmacokinetics and Pharmacodynamics of Digoxin

Clinical pharmacology in drug development, 2013-01, Vol.2 (1), p.90-98

2013

Link zum Volltext

Verfügbarkeit prüfen

Interaction of Single-Dose Ezetimibe and Steady-State Cyclosporine in Renal Transplant Patients

Journal of clinical pharmacology, 2006-03, Vol.46 (3), p.328-336

2006

Link zum Volltext

Verfügbarkeit prüfen

Mometasone furoate nasal spray : A review of safety and systemic effects

Drug safety, 2007-01, Vol.30 (4), p.317-326

2007

Link zum Volltext

Verfügbarkeit prüfen

Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure

Clinical science (1979), 1996-09, Vol.91 (3), p.283

1996

Link zum Volltext

Verfügbarkeit prüfen

No differences in the pharmacodynamics and pharmacokinetics of the thrombin receptor antagonist vorapaxar between healthy Japanese and Caucasian subjects

European journal of clinical pharmacology, 2012-03, Vol.68 (3), p.291-300

2012

Link zum Volltext

Verfügbarkeit prüfen

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers

Clinical pharmacology in drug development, 2018-02, Vol.7 (2), p.143-150

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic and pharmaco-kinetic interaction between fenofibrate and ezetimibe

Current medical research and opinion, 2004-08, Vol.20 (8), p.1197-1207

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

KollektionEZB Free E-Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Humans
(30)
Pharmacology & Pharmacy
(29)
Male
(28)
Adult
(27)
Biological And Medical Sciences
(20)
Medical Sciences
(19)
Pharmacokinetics
(19)
Pharmacology. Drug Treatments
(19)
Female
(18)
Drug Interactions
(14)
Middle Aged
(14)
Vorapaxar
(12)
Ezetimibe
(11)
Area Under Curve
(10)
Azetidines - Pharmacokinetics
(9)
Pharmacodynamics
(9)
Adolescent
(8)
Anticholesteremic Agents - Pharmacokinetics
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects

Antihypertensive Response to Ketanserin: Influence of Race and Weight

Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects

Disposition of 14C-eptifibatide after intravenous administration to healthy men

Drug interactions involving renal transport mechanisms: an overview

The Effect of Antacid and Cimetidine on the Oral Absorption of the Antifungal Agent SCH 39304

The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe

Effect of Food, Antacid, and Age on the Pharmacokinetics of the Oral Thrombin Receptor Antagonist Vorapaxar (SCH 530348) in Healthy Volunteers

Effect of Food on the Oral Bioavailability of Isosorbide-5-Mononitrate Administered as an Extended-Release Tablet

The Effect of Multiple Doses of Ketoconazole or Rifampin on the Single- and Multiple-Dose Pharmacokinetics of Vorapaxar

Effect of the thrombin receptor antagonist (PAR-1) vorapaxar on QT/QTc interval in healthy volunteers: A randomized, placebo- and positive-controlled, parallel group trial

Effects of Ezetimibe on Cyclosporine Pharmacokinetics in Healthy Subjects

Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin

Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers

Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device

An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects

Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactions

Influence of Food on the Oral Bioavailability of Loratadine and Pseudoephedrine from Extended-Release Tablets in Healthy Volunteers

The Influence of Multiple-Dose Vorapaxar, an Oral PAR-1 Receptor Antagonist, on the Single-Dose Pharmacokinetics and Pharmacodynamics of Digoxin

Interaction of Single-Dose Ezetimibe and Steady-State Cyclosporine in Renal Transplant Patients

Mometasone furoate nasal spray : A review of safety and systemic effects

Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure

No differences in the pharmacodynamics and pharmacokinetics of the thrombin receptor antagonist vorapaxar between healthy Japanese and Caucasian subjects

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers

Pharmacodynamic and pharmaco-kinetic interaction between fenofibrate and ezetimibe

Aktive Filter

Suchergebnisse filtern